GEORGE R BLUMENSCHEIN to TNF-Related Apoptosis-Inducing Ligand
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about TNF-Related Apoptosis-Inducing Ligand.
Connection Strength
0.026
-
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial. J Thorac Oncol. 2013 May; 8(5):658-61.
Score: 0.026
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.